Zheng Chen
- Endocrine and Autonomic Systems top 10%
- Immunology top 10%
- Aging top 10%
- Cancer Research top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
-
- Allergic Rhinitis and Sensitization 8
-
- Ferroptosis and cancer prognosis 8
- Gastric Cancer Management and Outcomes 6
-
- Asthma and respiratory diseases 8
-
- Sinusitis and nasal conditions 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Liver physiology and pathology 3
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zheng Chen
88 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 136
- Endocrine and Autonomic Systems 93
- Immunology 276
- Aging 20
- Cancer Research 171
- Oncology 257
Countries citing papers authored by Zheng Chen
This map shows the geographic impact of Zheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Chen more than expected).
Fields of papers citing papers by Zheng Chen
This network shows the impact of papers produced by Zheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Chen. The network helps show where Zheng Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zheng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 43 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 6 | |
| 12 | 2017 | 50 | |
| 13 | 2016 | 6 | |
| 14 | 2014 | 40 | |
| 15 | 2012 | 69 | |
| 16 | Comparisons Among Four Chemotherapeutic Regimens for Advanced Non-small Cell Lung Cancer | 2006 | 2 |
| 17 | Research on design wind-velocity of Yangluo Yangtse River Bridge in Wuhan | 2003 | 2 |
| 18 | 2003 | 26 | |
| 19 | THE ROOSTING HABIT OF THE SPINY LOBSTER Panulirus stimpsoni | 2001 | 3 |
| 20 | 2001 | 100 |
About Zheng Chen
Zheng Chen is a scholar working on Immunology and Allergy, Otorhinolaryngology and Hepatology, having authored 95 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Allergic Rhinitis and Sensitization (8 papers), Ferroptosis and cancer prognosis (8 papers), Asthma and respiratory diseases (8 papers), Gastric Cancer Management and Outcomes (6 papers), Sinusitis and nasal conditions (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (93 citations), Immunology (276 citations) and Aging (20 citations). Zheng Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia Yu, Yuetao Song, Dehua Chui, Yong‐Sheng Xiao, Mincheng Yu, Yongfeng Xu, Binghai Zhou, Dunfa Peng, Jun Hong and Vikas Sehdev. Their work appears in journals such as Annals of Translational Medicine, BMC Cancer, Cancer Research, International Immunopharmacology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.